title: Levatiracetam for the management of Lance-Adams syndrome.
abstract: Chronic post-hypoxic myoclonus, also known as Lance-Adams syndrome (LAS) is a neurological complication characterized by uncontrolled myoclonic jerks following cardiac arrest. In this article, clinical manifestation and symptomatic treatment options are discussed especially concerning the rationale of use of levatiracetam in patients with Lance-Adams syndrome. Clinical presentation is action myoclonus associated with cerebellar ataxia, postural imbalance, and very mild intellectual deficit. An 18-year-old female patient was admitted to our intensive care unit in a coma. She had a cardiorespiratory arrest after a splenectomy in a local hospital. Then, myoclonic movements were continuously observed over the entire body, including the face. On day 14 of hospitalization, we started levatiracetam 1000 mg daily. The frequency of convulsion movements was reduced. The patient level of consciousness was 15 on the Glasgow coma scale (GCS) on the Mini-Mental State Examination (MMSE) score was 23 out of 30. She was later transferred to the rehabilitation department. Vigilance is required to ensure early diagnosis and timely intervention for the myoclonic jerks. We would like to emphasize that LAS should be considered in patients with the myoclonic jerks following cardiac arrest and that levatiracetam therapy may be useful as treatment.
authors.affiliation: Department of Neurology, Elbistan State Hospital, Kahramanmaras, Turkey.
authors.forename: Faik
authors.initials: F
authors.lastname: Ilik
authors.affiliation: Department of Neurosurgery, Faculty of Medicine, Mevlana University, Konya, Turkey.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Kemal Ilik
authors.affiliation: Department of Neurosurgery, Faculty of Medicine, Başkent University, Konya, Turkey.
authors.forename: Ilker
authors.initials: I
authors.lastname: Cöven
keywords: Lance-Adams syndrome; Levatiracetam; Post-hypoxic myoclonus